Estrogen Receptor Positive (ER+) Breast Cancer Outlook 2017 Industry Estrogen Receptor Positive (ER+) Breast Cancer

Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2017 Date: May 2017 No. of pages: 81 Single User License: US $2450 E-mail: [email protected] Tel: + 1 888 391 5441